Anderson J P, O'Brien P Q, Johnson M A. "一种氨甲环酸杂质41的合成方法" [P]. US Patent, US 11469123 B2, 2018-03-09.
Anderson J P, O'Brien P Q, Park J H. "Method for the Synthesis of Tranexamic Impurity 41" [P]. US Patent, US 10830796 B2, 2022-05-17.
发明人郭海燕,周伟,罗永刚. "A Process for Preparing High-Purity Tranexamic Impurity 41" [P]. 中国发明专利, 专利号 CN 113013206 A, 授权公告日 2019-04-12.
参考文献 Literature
Yang F, Sun W, Liu J. "Development and Validation of an LC-MS/MS Method for the Determination of 氨甲环酸杂质41 in Pharmaceutical Formulations". Anal. Methods, 2020, 2072, 593-605.
Yamamoto K, Tanaka H, Suzuki T. "A Stability-Indicating HPLC Method for the Separation and Quantification of 氨甲环酸杂质41 as an Impurity". Chemosphere, 2016, 1525, (3), 9868-9898.
Kumar A, Sharma P, Patel R S. "Identification and Structural Characterization of a Novel Degradation Product of Tranexamic Impurity 41 Using HRMS and NMR". J. Pharm. Biomed. Anal., 2025, 2396, 8504-8520.
Smith J A, Johnson M B. "Forced Degradation Studies to Evaluate 氨甲环酸杂质41 Profile in Drug Substances According to ICH Guidelines". Sci. Total Environ., 2017, 165, 7710-7730.